Transcranial Magnetic Stimulation Clinical Trial
Official title:
Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) as an Adjunct to AI Enabled Remedial Intervention in School Going Children (Aged 6-18 Years) Having Specific Learning Disorder With Dyslexia
Dyslexia is the most common neurobehavioral disorder affecting children, with prevalence rates ranging from 17.5% to 21%. Studies have shown incomplete response to remediation and behavioural therapies in children with dyslexia. Evidence from neuroimaging studies as well as neuromodulation studies supporting a neurobiological basis of dyslexia is extensive according to which under-activation and poor connectivity in the underlying pathways for language and reading is the primary pathophysiology underlying reading difficulties. Evidence from studies on neuromodulation have shown that by combining remedial intervention with neuromodulation there is a synergistic effect through the mechanism of long term potentiation. In view of the above mentioned our study aims to investigate the role of Hf rTMS as an adjunct to AI enabled remedial intervention in children with dyslexia in improving their reading abilities.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 18 Years |
Eligibility | Inclusion Criteria: - Indian school going children aged 6-18 years having specific learning disorder (SLD) with dyslexia diagnosed by DSM-5 criteria - English as one of the languages in school - Parents willing for the study Exclusion Criteria: - Parents not willing to participate or follow up at desired frequency of study - Child who has already received or is on remedial intervention within last 12 weeks provided by Child Psychologist/ Clinician/Psychiatrist - Children who participated in a completed DM dissertation on remedial program in SLD - Child already on any psychotropic medications - Neurological or psychiatric disorder other than comorbid disorders of SLD - Uncontrolled epilepsy as defined by seizure frequency >1/month for preceding 3 months - Severe concurrent illness or disease or unstable medical conditions - Any contraindications for MRI like presence of pacemaker, metallic implant - Any contraindications for TMS like Implanted electronic device and non-removable metallic objects near coil e.g. pacemaker, cochlear implant; presence of ferromagnetic metal in the head outside the mouth; on medication lowering seizure threshold. |
Country | Name | City | State |
---|---|---|---|
India | All India Institute of Medical Sciences | Delhi |
Lead Sponsor | Collaborator |
---|---|
All India Institute of Medical Sciences, New Delhi |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement in reading abilities of the participants as assessed by CTOPP-2 scores at 6 and 12 weeks from baseline. | Difference in mean of CTOPP-2 scores at 6 and 12 weeks from baseline. CTOPP-2 - Comprehensive Test Of Phonological Processing Tool, 2nd edition
-tool has been explained in the study description section above. |
From baseline to 6 and 12 weeks | |
Primary | Improvement in reading abilities of the participants as assessed by GLAD scores at 6 and 12 weeks from baseline. | Difference in mean of GLAD scores at 6 and 12 weeks from baseline. GLAD - Grade level Assessment Device Tool The tool has been explained in the study description section above. | From baseline to 6 and 12 weeks | |
Primary | Improvement in reading abilities of the participants as assessed by WRAT-5 scores at 6 and 12 weeks from baseline. | Difference in mean of WRAT5 scores at 6 and 12 weeks from baseline. WRAT-5 - Wide Range achievement test, 5th edition The tool has been explained in the study description section above. | From baseline to 6 and 12 weeks | |
Primary | Improvement in reading abilities of the intervention group (who received Hf-rTMS with AI based remedial intervention) as assessed by CTOPP-2 scores at 6 weeks as compared to controls (who received only AI based remedial intervention). | Difference in mean of change in CTOPP-2 scores at 6 weeks between the intervention group and the retrospective data of controls CTOPP-2 - Comprehensive Test Of Phonological Processing Tool, 2nd edition The tool has been explained in the study description section above. | From baseline to 6 weeks | |
Primary | Improvement in reading abilities of the intervention group (who received Hf-rTMS with AI based remedial intervention) as assessed by GLAD scores at 6 weeks as compared to controls (who received only AI based remedial intervention). | Difference in mean of change in GLAD scores at 6 weeks between the intervention group and the retrospective data of controls GLAD - Grade level Assessment Device Tool The tool has been explained in the study description section above. | From baseline to 6 weeks | |
Primary | Improvement in reading abilities of the intervention group (who received Hf-rTMS with AI based remedial intervention) as assessed by WRAT5 scores at 6 weeks as compared to controls (who received only AI based remedial intervention). | Difference in mean of change in WRAT5 scores at 6 weeks between the intervention group and the retrospective data of controls WRAT-5 - Wide Range achievement test, 5th edition The tool has been explained in the study description section above. | From baseline to 6 weeks | |
Secondary | To compare the domain wise change CTOPP-2 scores of participants pre and post intervention | Difference in mean of Domain wise CTOPP2 score at 6 and 12 weeks from baseline CTOPP-2 - Comprehensive Test Of Phonological Processing Tool, 2nd edition
- details of the tools have been described in the study description section above. |
From baseline to 6 and 12 weeks | |
Secondary | To compare the domain wise change WRAT-5 scores of participants pre and post intervention | Difference in mean of Domain wise WRAT-5 score at 6 and 12 weeks from baseline WRAT-5 - Wide Range achievement test, 5th edition
- details of the tools have been described in the study description section above |
From baseline to 6 and 12 weeks | |
Secondary | To evaluate the persistence of effect of Hf rTMS in children with dyslexia at 24 weeks as assessed by WRAT5 scores | Difference in mean of WRAT-5 scores at 24 weeks from 12 weeks and from baseline WRAT-5 - Wide Range achievement test, 5th edition The tool has been explained in the study description section above. | From baseline to 24 weeks from 12 weeks and | |
Secondary | To evaluate the persistence of effect of Hf rTMS in children with dyslexia at 24 weeks as assessed by GLAD scores | Difference in mean of GLAD scores at 24 weeks from 12 weeks and from baseline GLAD - Grade level Assessment Device Tool The tool has been explained in the study description section above. | From baseline to 24 weeks from 12 weeks and | |
Secondary | To evaluate the persistence of effect of Hf rTMS in children with dyslexia at 24 weeks as assessed by CTOPP-2 scores | Difference in mean of CTOPP-2 scores at 24 weeks from 12 weeks and from baseline CTOPP-2 - Comprehensive Test Of Phonological Processing Tool, 2nd edition The tool has been explained in the study description section above. | From baseline to 24 weeks from 12 weeks and | |
Secondary | To evaluate the cortical excitability parameter - RMT pre and post intervention | Mean change in RMT from baseline at 6 weeks, 12 weeks and 24 weeks into the study RMT - Resting Motor Threshold | at 6 weeks, 12 weeks and 24 weeks into the study | |
Secondary | To evaluate the resting state functional networks and brain activation profile during phonological tasks using functional MRI in dyslexic children pre and post intervention | Differences in functional connectivity and Difference in activation scores of ROI (region of Interest) during the phonological tasks on f MRI from baseline at 12 weeks (at end of intervention) | from baseline at 12 weeks (at end of intervention) | |
Secondary | To describe adverse events noted during Hf rTMS | AE= Positive increase in any of the ROS (review of systems) criteria compared to pre therapy No of patients who have had atleast 1 AE AE rate: ratio of sessions with adverse events divided by total sessions | 12 weeks | |
Secondary | To describe subjective improvement as assessed by parents and teachers of children with dyslexia | Subjective Improvement as assessed by the parent and teacher on a 7 point Likert scale | at 6 weeks, 12 weeks and 24 weeks from baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04927364 -
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
|
N/A | |
Recruiting |
NCT06193278 -
Individual Neuromodulation for PDS
|
N/A | |
Recruiting |
NCT05973019 -
rTMS Improves Functions in Spinocerebellar Ataxia
|
N/A | |
Completed |
NCT05074524 -
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
|
N/A | |
Recruiting |
NCT05889117 -
Brain Stimulation for Concussion
|
N/A | |
Recruiting |
NCT03974659 -
Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor Patients
|
N/A | |
Recruiting |
NCT05613686 -
Theta Burst Stimulation for Motor Recovery
|
N/A | |
Completed |
NCT04014491 -
The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome
|
N/A | |
Recruiting |
NCT05914038 -
Individualized rTMS for Motor Recovery in Stroke Patients
|
N/A | |
Recruiting |
NCT06084455 -
TMS-evoked Potentials During Aerobic Exercise
|
N/A | |
Completed |
NCT05566444 -
TMS-evoked Potentials During Heat Pain
|
N/A | |
Enrolling by invitation |
NCT04313530 -
TMS Treatment in Multiple System Atrophy With Fatigue
|
N/A | |
Completed |
NCT04209309 -
Repetitive Transcranial Magnetic Stimulation as a Potential Tool to Reduce Sexual Arousal
|
N/A | |
Terminated |
NCT04486222 -
Accelerated Bilateral rTMS on Geriatric Depression
|
N/A | |
Recruiting |
NCT05192759 -
Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Freezing of Gait
|
N/A | |
Recruiting |
NCT05467657 -
Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke
|
N/A | |
Recruiting |
NCT05896332 -
rTMS in Older Adults With MCI and AUD
|
Phase 1 | |
Recruiting |
NCT04727177 -
Precision-targeted Transcranial Magnetic Stimulation in the Treatment of Primary Dystonia
|
Early Phase 1 | |
Recruiting |
NCT04906603 -
Theta Burst Stimulation for Headaches After Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT03590327 -
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
|
N/A |